These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25054200)

  • 1. Mining TCGA data using Boolean implications.
    Sinha S; Tsang EK; Zeng H; Meister M; Dill DL
    PLoS One; 2014; 9(7):e102119. PubMed ID: 25054200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
    Song X; Ji J; Gleason KJ; Yang F; Martignetti JA; Chen LS; Wang P
    Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S52-S65. PubMed ID: 31227599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNAmet: an R package for integrating copy number, methylation and expression data.
    Louhimo R; Hautaniemi S
    Bioinformatics; 2011 Mar; 27(6):887-8. PubMed ID: 21228048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.
    Bozdag S; Li A; Riddick G; Kotliarov Y; Baysan M; Iwamoto FM; Cam MC; Kotliarova S; Fine HA
    PLoS One; 2013; 8(4):e62982. PubMed ID: 23658659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.
    Neilsen BK; Sleightholm R; McComb R; Ramkissoon SH; Ross JS; Corona RJ; Miller VA; Cooke M; Aizenberg MR
    J Neurooncol; 2019 Mar; 142(1):111-118. PubMed ID: 30535594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
    Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
    Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
    Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
    Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer.
    McDonald ME; Salinas EA; Devor EJ; Newtson AM; Thiel KW; Goodheart MJ; Bender DP; Smith BJ; Leslie KK; Gonzalez-Bosquet J
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.
    Ping Y; Zhang H; Deng Y; Wang L; Zhao H; Pang L; Fan H; Xu C; Li F; Zhang Y; Gong Y; Xiao Y; Li X
    Mol Biosyst; 2014 Aug; 10(8):2031-42. PubMed ID: 24911613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue.
    Luo K; Luo D; Wen H
    Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional diversity of long-term glioblastoma survivors.
    Gerber NK; Goenka A; Turcan S; Reyngold M; Makarov V; Kannan K; Beal K; Omuro A; Yamada Y; Gutin P; Brennan CW; Huse JT; Chan TA
    Neuro Oncol; 2014 Sep; 16(9):1186-95. PubMed ID: 24662514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MethCNA: a database for integrating genomic and epigenomic data in human cancer.
    Deng G; Yang J; Zhang Q; Xiao ZX; Cai H
    BMC Genomics; 2018 Feb; 19(1):138. PubMed ID: 29433427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
    PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.